Mycophenolate Mofetil and Bronchiectasis in Kidney Transplant Patients: A Possible Relationship
Authors:
- Mieneke RookMRMieneke Rook
- Dirkje S. PostmaDPDirkje S. Postma
- Eric J. van der JagtEJEric J. van der Jagt
- Cees A. van MinnenCMCees A. van Minnen
- Jaap J.HOman van der HeideJHJaap J.HOman van der Heide
- Rutger J. PloegRPRutger J. Ploeg
- Willem J. van SonWSWillem J. van Son
- 1 January 2006
- journal article
- case report
- Published by Wolters Kluwer Health in Transplantation
- Vol. 81 (2) , 287-289
Abstract
Bronchiectasis is a rare acquired condition, generally resulting from long-term chronic pulmonary inflammation. Mycophenolate mofetil (in short, mofetil) is a commonly used immunosuppressant in kidney transplantation. In the literature, there is no report of a relationship between mofetil use and development of bronchiectasis. Five kidney transplant patients developed complaints of cough, dyspnea, and abundant sputum production without apparent cause. Pulmonary complaints started at a range of 0–20 months after the start of mofetil treatment. Lesions were classified as bronchiectasis(-like), based on clinical presentation, chest x-ray, and computed tomography scan. Withdrawal of mofetil greatly relieved pulmonary complaints. Since the first kidney transplantation in our center in 1968, we have had no diagnosis of bronchiectasis in over 1,500 patients without mofetil treatment. These cases suggest an association between mofetil and development of bronchiectasis. Converting mofetil to another immunosuppressive drug should be considered when unexplained pulmonary complaints develop in patients receiving mofetil.Keywords
This publication has 13 references indexed in Scilit:
- Improved outcome of pediatric kidney transplantations in the Netherlands – Effect of the introduction of mycophenolate mofetil?Pediatric Transplantation, 2005
- Unusual presentation of herpes virus infections in renal transplant recipients exposed to high mycophenolic acid plasma concentrationsTransplant Infectious Disease, 2003
- BronchiectasisNew England Journal of Medicine, 2002
- In vitro effects of mycophenolic acid on the nucleotide pool and on the expression of adhesion molecules of human umbilical vein endothelial cellsClinica Chimica Acta, 2001
- Mycophenolate mofetil and its mechanisms of actionImmunopharmacology, 2000
- The use of mycophenolate mofetil in transplant recipientsImmunopharmacology, 2000
- A RANDOMIZED DOUBLE-BLIND, MULTICENTER PLASMA CONCENTRATION CONTROLLED STUDY OF THE SAFETY AND EFFICACY OF ORAL MYCOPHENOLATE MOFETIL FOR THE PREVENTION OF ACUTE REJECTION AFTER KIDNEY TRANSPLANTATION1Transplantation, 1999
- IgG subclasses in the serum and sputum from patients with bronchiectasisThorax, 1998
- The Primary ImmunodeficienciesNew England Journal of Medicine, 1995
- The Use of Intravenous Immune Globulin in Immunodeficiency DiseasesNew England Journal of Medicine, 1991